COVID-19 Impact on Canine Arthritis Treatment Market, Global Research Reports 2020-2021
Table of Contents1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Canine Arthritis Treatment Industry
1.7 COVID-19 Impact: Canine Arthritis Treatment Market Trends
2 Global Canine Arthritis Treatment Quarterly Market Size Analysis
2.1 Canine Arthritis Treatment Business Impact Assessment - COVID-19
2.1.1 Global Canine Arthritis Treatment Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Canine Arthritis Treatment Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 By Players, Global Canine Arthritis Treatment Quarterly Market Size, 2019 VS 2020
3.2 By Players, Canine Arthritis Treatment Headquarters and Area Served
3.3 Date of Key Players Enter into Canine Arthritis Treatment Market
3.4 Key Players Canine Arthritis Treatment Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Canine Arthritis Treatment Segments, By Type
4.1 Introduction
1.4.1 Non-Steroidal Anti-Inflammatory Drugs
1.4.2 Opioids
4.2 By Type, Global Canine Arthritis Treatment Market Size, 2019-2021
5 Impact of Covid-19 on Canine Arthritis Treatment Segments, By Application
5.1 Overview
5.5.1 Veterinary Hospitals and Clinics
5.5.2 Drug Stores
5.5.3 E-commerce
5.2 By Application, Global Canine Arthritis Treatment Market Size, 2019-2021
5.2.1 By Application, Global Canine Arthritis Treatment Market Size by Application, 2019-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Elanco (Eli Lilly and Company)
7.1.1 Elanco (Eli Lilly and Company) Business Overview
7.1.2 Elanco (Eli Lilly and Company) Canine Arthritis Treatment Quarterly Revenue, 2020
7.1.3 Elanco (Eli Lilly and Company) Canine Arthritis Treatment Product Introduction
7.1.4 Elanco (Eli Lilly and Company) Response to COVID-19 and Related Developments
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Business Overview
7.2.2 Boehringer Ingelheim Canine Arthritis Treatment Quarterly Revenue, 2020
7.2.3 Boehringer Ingelheim Canine Arthritis Treatment Product Introduction
7.2.4 Boehringer Ingelheim Response to COVID-19 and Related Developments
7.3 Zoetis Inc
7.3.1 Zoetis Inc Business Overview
7.3.2 Zoetis Inc Canine Arthritis Treatment Quarterly Revenue, 2020
7.3.3 Zoetis Inc Canine Arthritis Treatment Product Introduction
7.3.4 Zoetis Inc Response to COVID-19 and Related Developments
7.4 Vetoquinol S.A.
7.4.1 Vetoquinol S.A. Business Overview
7.4.2 Vetoquinol S.A. Canine Arthritis Treatment Quarterly Revenue, 2020
7.4.3 Vetoquinol S.A. Canine Arthritis Treatment Product Introduction
7.4.4 Vetoquinol S.A. Response to COVID-19 and Related Developments
7.5 Bayer AG
7.5.1 Bayer AG Business Overview
7.5.2 Bayer AG Canine Arthritis Treatment Quarterly Revenue, 2020
7.5.3 Bayer AG Canine Arthritis Treatment Product Introduction
7.5.4 Bayer AG Response to COVID-19 and Related Developments
7.6 Aratana Therapeutics Inc
7.6.1 Aratana Therapeutics Inc Business Overview
7.6.2 Aratana Therapeutics Inc Canine Arthritis Treatment Quarterly Revenue, 2020
7.6.3 Aratana Therapeutics Inc Canine Arthritis Treatment Product Introduction
7.6.4 Aratana Therapeutics Inc Response to COVID-19 and Related Developments
7.7 Norbrook Laboratories Limited
7.7.1 Norbrook Laboratories Limited Business Overview
7.7.2 Norbrook Laboratories Limited Canine Arthritis Treatment Quarterly Revenue, 2020
7.7.3 Norbrook Laboratories Limited Canine Arthritis Treatment Product Introduction
7.7.4 Norbrook Laboratories Limited Response to COVID-19 and Related Developments
7.8 VetStem Biopharma
7.8.1 VetStem Biopharma Business Overview
7.8.2 VetStem Biopharma Canine Arthritis Treatment Quarterly Revenue, 2020
7.8.3 VetStem Biopharma Canine Arthritis Treatment Product Introduction
7.8.4 VetStem Biopharma Response to COVID-19 and Related Developments
7.9 Dechra Pharmaceuticals Plc
7.9.1 Dechra Pharmaceuticals Plc Business Overview
7.9.2 Dechra Pharmaceuticals Plc Canine Arthritis Treatment Quarterly Revenue, 2020
7.9.3 Dechra Pharmaceuticals Plc Canine Arthritis Treatment Product Introduction
7.9.4 Dechra Pharmaceuticals Plc Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
9.1 About US
9.2 Disclaimer
List of TablesTable 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Canine Arthritis Treatment Assessment
Table 9. COVID-19 Impact: Canine Arthritis Treatment Market Trends
Table 10. COVID-19 Impact Global Canine Arthritis Treatment Market Size
Table 11. Global Canine Arthritis Treatment Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Canine Arthritis Treatment Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Canine Arthritis Treatment Market Growth Drivers
Table 14. Global Canine Arthritis Treatment Market Restraints
Table 15. Global Canine Arthritis Treatment Market Opportunities
Table 16. Global Canine Arthritis Treatment Market Challenges
Table 17. By Players, Canine Arthritis Treatment Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Canine Arthritis Treatment Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Canine Arthritis Treatment Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Canine Arthritis Treatment Market
Table 21. Key Players Canine Arthritis Treatment Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Canine Arthritis Treatment Market Size 2019-2021, (US$ Million)
Table 24. Global Canine Arthritis Treatment Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Canine Arthritis Treatment Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Canine Arthritis Treatment Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Canine Arthritis Treatment Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Canine Arthritis Treatment Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Canine Arthritis Treatment Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Canine Arthritis Treatment Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Canine Arthritis Treatment Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Canine Arthritis Treatment Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Canine Arthritis Treatment Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Canine Arthritis Treatment Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Canine Arthritis Treatment Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Canine Arthritis Treatment Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Canine Arthritis Treatment Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Canine Arthritis Treatment Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Canine Arthritis Treatment Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Canine Arthritis Treatment Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Canine Arthritis Treatment Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Canine Arthritis Treatment Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Canine Arthritis Treatment Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Canine Arthritis Treatment Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Canine Arthritis Treatment Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Canine Arthritis Treatment Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Canine Arthritis Treatment Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Canine Arthritis Treatment Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Canine Arthritis Treatment Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Canine Arthritis Treatment Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Canine Arthritis Treatment Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Canine Arthritis Treatment Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Canine Arthritis Treatment Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Canine Arthritis Treatment Market Size, 2019-2021 (US$ Million)
Table 57. Elanco (Eli Lilly and Company) Business Overview
Table 58. Elanco (Eli Lilly and Company) Canine Arthritis Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Elanco (Eli Lilly and Company) Canine Arthritis Treatment Product
Table 60. Elanco (Eli Lilly and Company) Response to COVID-19 and Related Developments
Table 61. Boehringer Ingelheim Business Overview
Table 62. Boehringer Ingelheim Canine Arthritis Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Boehringer Ingelheim Canine Arthritis Treatment Product
Table 64. Boehringer Ingelheim Response to COVID-19 and Related Developments
Table 65. Zoetis Inc Business Overview
Table 66. Zoetis Inc Canine Arthritis Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Zoetis Inc Canine Arthritis Treatment Product
Table 68. Zoetis Inc Response to COVID-19 and Related Developments
Table 69. Vetoquinol S.A. Business Overview
Table 70. Vetoquinol S.A. Canine Arthritis Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Vetoquinol S.A. Canine Arthritis Treatment Product
Table 72. Vetoquinol S.A. Response to COVID-19 and Related Developments
Table 73. Bayer AG Business Overview
Table 74. Bayer AG Canine Arthritis Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Bayer AG Canine Arthritis Treatment Product
Table 76. Bayer AG Response to COVID-19 and Related Developments
Table 77. Aratana Therapeutics Inc Business Overview
Table 78. Aratana Therapeutics Inc Canine Arthritis Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Aratana Therapeutics Inc Canine Arthritis Treatment Product
Table 80. Aratana Therapeutics Inc Response to COVID-19 and Related Developments
Table 81. Norbrook Laboratories Limited Business Overview
Table 82. Norbrook Laboratories Limited Canine Arthritis Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Norbrook Laboratories Limited Canine Arthritis Treatment Product
Table 84. Norbrook Laboratories Limited Response to COVID-19 and Related Developments
Table 85. VetStem Biopharma Business Overview
Table 86. VetStem Biopharma Canine Arthritis Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. VetStem Biopharma Canine Arthritis Treatment Product
Table 88. VetStem Biopharma Response to COVID-19 and Related Developments
Table 89. Dechra Pharmaceuticals Plc Business Overview
Table 90. Dechra Pharmaceuticals Plc Canine Arthritis Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Dechra Pharmaceuticals Plc Canine Arthritis Treatment Product
Table 92. Dechra Pharmaceuticals Plc Response to COVID-19 and Related Developments
List of FiguresFigure 1. Canine Arthritis Treatment Product Picture
Figure 2. Canine Arthritis Treatment Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Canine Arthritis Treatment Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Canine Arthritis Treatment Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Canine Arthritis Treatment Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Canine Arthritis Treatment Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Canine Arthritis Treatment Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Canine Arthritis Treatment Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Canine Arthritis Treatment Market Size Market Share, 2019-2021